课题基金 / 基金详情

Molecular Pathopbysiological Reseatch of ubiquitin ligase,human Nodd4L, for the development ofessentialhyportension

Molecular Pathopbysiological Reseatch of ubiquitin ligase,human Nodd4L, for the development ofessentialhyportension
泛素连接酶、人Nodd4L对原发性低血压发生的分子病理学研究
批准号:
18590898
负责人:
ISHIGAMI Tomoaki
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

ISHIGAMI Tomoaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Net sodium balances in humans are maintained through various ion transporters expressed along the entire nephron. Among these ion transporters, epithelial sodium channels (ENaC) located along the aldosterone-sensitive distal nephron(ASDN)play a pivotal role in the homeostasis of sodium. balance. This is supported by analyses of inherited hypertensive disorders, showing that genes encoding ENaC and other modulatory proteins cause hereditary hypertension, such as Liddle's syndrome. Among various modulating proteins, E8 ubiquitin ligase, Nedd4L, binds the PY motif of ENaC COOH terminals and catalyzes ubiquitilation of the NH terminal of the protein for subsequent degradation. Both evolutionarily conserved and evolutionarily new C2 domains of human Nedd4L, a cryptic splice variant resulting in a disrupted isoform product formed by a frame shift mutation, were reported previously, We focused on one of the isoforms, isoform I, generated by SNP (rs4149601), and studied its expression and interactions with other isoforms by molecular biological, immmohistochemical, and electrophysiological methods. We found that isoform I may interact with other human isoforms in a dominant-negative fashion. Such interactions might abnormally increase sodium reabsorption, Taken together, our analyses suggest that the human Nedd4L gene, especially the evolutionerily new isoform I, is a candidate gene for hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2007
期刊: Clin Exp Hypertens. 29(1)
影响因子: --
作者: [Tamura K, Ishigami T, et al.]
通讯作者: et al.
ARB or ACEI, that is the Question. Editorial Comment
ARB 还是 ACEI,这就是问题所在。
DOI: --
发表时间: 2006
期刊: Hypertension Research 29
影响因子: --
作者: [Ishigami, T, et al.]
通讯作者: et al.
Expression of MAK-V/Hunk in Renal Distal Tubles and Its Possibe・・・
MAK-V/Hunk在肾远端小管中的表达及其可能的作用
DOI: --
发表时间: 2007
期刊: Am J Physiol Renal Phsiol, Epub ahead
影响因子: --
作者: [Sakai M, Ishigami T, et al.]
通讯作者: et al.
DOI: --
发表时间: 2006
期刊: Heart and Vessels 21(4)
影响因子: --
作者: [Uchino K, Ishigami T, et al.]
通讯作者: et al.
17
    Salt Sensitivity, Hypertension and Tubular Mechanism
    • 批准号:
      17K09730
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2017
    • 负责人:
      ISHIGAMI Tomoaki
    • 依托单位:
    Elucidation and Expansion of Molecular Physiology of Salt Sensitivity and Hypertensin Based on Tubular Mechanism.
    • 批准号:
      26461257
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      ISHIGAMI Tomoaki
    • 依托单位:
    Analyses of molecular mechanism of hypertensive cardio-renal relationships focusing on post-transcriptional regulations of ion-transporters.
    • 批准号:
      23591221
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      ISHIGAMI Tomoaki
    • 依托单位:
    Identifications for molecular mechanisms of essential hypertension in terms of urinary tubular ion transporter and human NEDD4L.
    • 批准号:
      20590978
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2008
    • 负责人:
      ISHIGAMI Tomoaki
    • 依托单位:
    国内基金
    海外基金
    NEDD4L调控STK11泛素化通过SIRT1/PGC1α介导线粒体稳态失衡抑制hMSCs成骨分化的机制研究
    • 批准号:
      2026JJ81912
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      董娜
    • 依托单位:
    E3泛素连接酶NEDD4L介导NRF2降解在多发性骨髓瘤硼替佐米耐药中的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      曹文
    • 依托单位:
    E3连接酶NEDD4L介导AQP9泛素化降解促进肝细胞癌侵袭转移的机制研究
    • 批准号:
      CSTB2023NSCQ-MSX0784
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2023
    • 负责人:
      张文广
    • 依托单位:
    Nedd4l促进树突状细胞抗原交叉提呈的效应及机制研究